Challenges and solutions: The present and future of cell therapies for T1D
Breakthrough T1D is funding research that supports manufactured islet cell source, survival, and protection and is also driving initiatives to…
Breakthrough T1D 2025 Government Day: 4 amazing days, 485 Congressional meetings, 370 sore feet
Breakthrough T1D headed to Washington D.C. where advocates held nearly 500 meetings with Members of Congress on behalf of the…
Letter from Aaron J. Kowalski, PhD, CEO of Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes research and advocacy organization, to Robert F. Kennedy Jr., United States Secretary of Health and Human Services (HHS)
Dear Secretary Kennedy, Congratulations on your confirmation as United States Secretary of Health and Human Services. On behalf of the…
2024 greatest T1D hits: A glance at this year’s achievements
While we look back on 2024, we can reflect upon the incredible progress we’ve made in advancing breakthroughs toward cures…
Orlando Brown, Jr. nominated for Walter Payton NFL Man of the Year Award
Orlando Brown, Jr. has been nominated for the Man of the Year Award in recognition of his outreach work with…
Meet Orlando Brown, Jr., a hero for T1D advocacy
Orlando Brown, Jr.'s commitment to type 1 diabetes (T1D) advocacy stems from his family’s journey with the disease.
Moving T1D forward through advocacy
Breakthrough T1D Chief Global Advocacy Officer Lynn Starr discusses how type 1 diabetes advocacy drives our mission progress forward...faster.
New ICD-10 Codes Will Help the T1D Community
On October 1st, the T1D community got a big win: the Centers for Medicare and Medicaid Servies (CMS) introduced a…
Advocating for progress and access
With the support of our grassroots advocates, our work helps advance treatments, influence policy, and improve access to care for…
Breaking through to Congress at 2024 Government Day
Our Advocates traveled to D.C. to reintroduce our organization and champion legislation and policy for the T1D community.
